NEW YORK ( TheStreet) -- AVANIR Pharmaceuticals (Nasdaq: AVNR) hit a new 52-week low Wednesday as it is currently trading at $1.97, below its previous 52-week low of $1.98 with 1.2 million shares traded as of 3:29 p.m. ET. Average volume has been 1.5 million shares over the past 30 days. AVANIR has a market cap of $283.1 million and is part of the health care sector and drugs industry. Shares are down 43.6% year to date as of the close of trading on Tuesday. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter